Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Anyone want to bet the financials submitted to the SEC are fraudulent? (I wouldn't take that bet.)
JMO.
Malc ... kudos for the nice new board!
I'll be lurking and interested to learn from the posts here. Interesting and important stuff!
Perhaps this is overly critical but you know me! One suggestion is about the mission ... the way it reads I want to answer that the ethics and philosophy of shady practises is that they are basically immoral! I don't think that is the intention or am I mis-reading? Perhaps better is to say "The mission is to talk about unethical practises of ..."??
Anyway, I salute you and members here for what you are doing. My basic philosophy is about the love of truth and I think this board is all about that in raising awareness. Thanks for the effort!
"The mission of the board will be to talk about the basic ethics and philosophy of trading and investing in stocks with a focus on the discussion of shady practices by both public companies and their promoters."
Harley, I love to hear your opinion about the trading. It cetainly feels suspicious that these great trial results remain unrecoginized by the market. In your experience with these types of stocks, do you know of cases where markets totally missed obviously positive trial results (inefficent market)? Or does trading most often more or less follow in tandem with fundamentals as would be more rationally expected?
Still have not figured out if I'm ahead or behind the market! For the record, I'm long ADXS ..
I agree... it should soon hit 2 and probably run a little past that.
I hold soooo many shares these trades are mostly insurance/defensive (but if I time it well then perhaps an opportunity to make more than just holding all the way up). If we shoot up without an opportunity to buyback these shares, I'll still be very happy.
This swing-trade strategy cost me a bit on NWBO, but worked very well on others (NTEK, PLSB, INO) so hopefully it will continue to work overall.
Crazy that we are still kind of waiting for that one big catalyst ... audit, Mother Goose, VODWIZ rollout ... just ONE of these and we should be sitting very well!
And sold them again @.0194 ... hice 25% quick gain!!
Sweet ... back up again!
HHSE ... successful swing-trade ... bought back my .019s @ .0154.
Got my wish ... picked up more shares @ .0154!
What happened to the volatility? Let's see my .0161 bid filled or let's see the .02's ... I remain loaded with shares so I'm happy either way!
It all depends upon the price they could fetch ... a negative about the spinoff is that synergies of multiple distribution channels would be lost.
Normally spin-offs are for business units independent to the core business.
HHSE - did anyone follow me? Went up 20% on Friday!
At 40%, Harleyman, the phrase that comes mind is 'balls of steel'!
Good luck to us all!
ok, you got me beat! I'm about 25% ...
HHSE ... I added some .0104s weeks ago but did not mention at the time as I was thinking folks would think I was crazy. I have such a huge position (relatively speaking) that I sold those same shares today @ .019 ... I still hold a very large % of my overall portfolio in HHSE.
My philosophy remains that shorts only win longer term only if there is bankruptcy or high dilution and I don't see a strong indication of either ... of course anything is possible but I see a greater indication of good things to come!
Most sources associate dilution according to an *increase* in shares over time, not a measure of the absolute number of shares. By this definition, HHSE is non-dilutive and -- yes -- it's a rarity in pinkland!
What's nice about HHSE, unlike many pinks, is that they have an ungagged transfer agent, meaning anyone can call to confirm the share structure.
http://en.wikipedia.org/wiki/Stock_dilution
"Stock dilution is an economic phenomenon resulting from the issue of ADDITIONAL common shares by a company."
http://www.fool.com/investing/high-growth/2006/04/28/foolish-fundamentals-stock-dilution.aspx
"Stock dilution refers to the issuance of ADDITIONAL stock by a company, for any purpose".
If you don't like the business fundamentals, or the company does not fit your personal investment style that's fine, but you can't say it's a bad investment based solely on the number of shares...
Here's more details from management about the OTC uplist:
http://www.hannoverhousemovies.blogspot.com/
That's absolutely fine if that's your investing prefernce. But please don't put down a company only because of its share price ... for the record, I'm also a buy and hold guy looking for a similar return over the longer-run based on business fundamentals (own both PLSB and HHSE).
In the same way, would it be fair for someone invested in Apple (who is holding for $1500 per share in the longer term) to criticize PLSB only because the shareprice is lower?
As a buy and hold guy, isn't it business fundamentals (earnings per share and growth relative to share price) that matter most?
I also don't buy into this 'altuistism'. If they 'save' me from owning the stock that only means some other person gets stuck with it... so why bother?
Trading of stocks, in and of itself is a zero-sum game. If I sell you a stock at $4 or sell it to you at $3, I'm better off in the first case and you are better off in the second case ... but collectively there is no real wealth created or destroyed by the share price going up or down.
Another way to say all this is essentially that -- all else being equal -- in a rational market if one company has double the shares outstanding the share price should be half. Company A would have a share price of 80 cents but company B with double the shares outstanding, but same business, should have a share price of 40 cents.
If both companies were to improve the (perceived?) fundamental value of the business by -- say 30% -- with company A would grow share price from 80 cents to $1.04 but company B would grow share price from 40 cents to 52 cents. In both cases, someone who invested a $1000 would make the same return ... although company B share price is cheaper, you would own double the shares.
I'm not sure I'm following the question ... so please be patient if I misunderstood. There are a LOT of business catalysts but I won't mention those explicitly as you are asking on the share count.
If company with fewer shares outstanding grows revenues, the shareprice could go from say $2 to $3 and you have a 50% return. HHSE might see the share price go from 2 cents to 3 cents, even with such a small 1 cent gain, as an investor you'd get the same 50% return ... in other words, it's the percentage increase not the absolute number that matters.
(I think it could go a lot higher than 3 cents ... say 8-10 cents over the next year but that is a separate question.)
To clarify, by uplist, I meant a higher tier within the OTC that comes with audited financials ... no need for a reverse-split.
About the dilution ... it has been EXTREMELY minimal ever since management took over the shell many years ago. They actually reduced A/S.
Of course, I'm glad to hear any opinions and feedback but I don't think dilution is a huge concern with this management (who owns the majority of common shares themselves.)
I've been following HHSE for quite a while, so please let me know if you have any questions ... as boh a value and growth stock I think it has great potential.
Check out HHSE... you can get their products at Amazon, Netflix, Redbox ... very low marketcap and hopefully an uplist coming.
It's both a value and growth stock.
INO ... "Inovio Pharmaceutical's DNA Vaccine for the Deadly MERS Virus Induces Robust Immune Response in Preclinical Trial"
http://ih.advfn.com/p.php?pid=nmona&article=60099283&symbol=INO
I missed that detail ... thanks so much for taking the time to clarify!
Thanks... looking good!
Thanks for posting ... a great sign of things to come!
I'm curious, the ticker HHSE is not in the Edgar search ... how did you find this?
Once audit is done we can argue if HHSE is more of a
VALUE stock or more of a GROWTH stock!
NWBO ... bought back in at 4.90 ... I missed some of the recent run but glad to be back in.
I would not be too worried. Oftentimes, retail items are sold at more than one store with more than one distributer.
For example, this exact same TV is for sale at both Walmart and Amazon ... crazy, but that is our capitalist system at work!
http://www.walmart.com/ip/Samsung-5500-Series-PN51F5500AFXZA-51-1080p-Plasma-HDTV/26934864
http://www.amazon.com/Samsung-PN51F5500-51-Inch-1080p-Plasma/dp/B00BCPGNVC/ref=sr_1_5?ie=UTF8&qid=1384453846&sr=8-5&keywords=samsung+5500
If you'd like to learn more look at the 6th slide on multiple distributors..
http://www2.tradeinsight.com/rs/meicpg/images/Building%20Your%20Business%20with%20Distributors.pdf
FVRG - nice Q! ... this performance should ensure my gains are locked-in ... lots of potential remaining if this growth continues.
http://ih.advfn.com/p.php?pid=nmona&article=60007711&symbol=FVRG
ForeverGreen Worldwide Corporation (OTCBB: FVRG), a leading provider of nutritional foods and other healthy products, today announced Q3 2013 earnings, for the quarter ended September 30, 2013.
Highlights included:
• Sales increased to $4,793,782 from $3,060,736 for Q3 2012, a 56.6% increase
• Gross Profit reached $1,527,159 compared to $974,562 during Q3 2012, a 56.7% increase
• Net Income for the quarter was $326,929 or $0.02 EPS versus a net loss of $107,585 or $0.01 EPS loss during the comparable period during 2012
Nine month highlights (for the period from 1/1/13 to 9/30/13) included:
• Sales increased to $11,495,871 from $9,781,990 for 2012, an increase of 17.5%
• Gross Profit increased to $3,673,766 from $2,997,775 last year, a 22.5% increase
• Net Income for the nine month period increased to $110,090 or $0.01 EPS compared to a net loss of $273,248 or a .02 EPS loss for the first nine months of 2012
“Since the pre-launch of FGXpress in January 2013, we have exceeded our original FGXpress growth goal by 27%. The Company operating expenses increased only 21.1%, showing that our business model is very scalable. With a strong third quarter and continued increasing sales for October and November, the Company feels confident that we are still on track to meet or exceed our sales forecast for 2013 of 30-35% growth with strong profitability. During 2014 our sales should increase to in excess of $30 million. We look forward to accelerated growth moving forward with all earnings, profit and cash metrics continuing to improve. I look forward to sharing recent progress on the conference call,” stated Ron Williams, CEO.
ADXS is tempting me ...
NWBO ... wow! I blew it (note to self ... when swing-trading always have some core shares) ... but very glad for you guys!
Great call!
Congrats you both! ... I wish I had core and swing-trade shares but my position is small ... I sold at 4.10 and hoping to get back in 3.70s...
NWBO ... running today ...
Terry -- thanks for sharing that very helpful information!
Simon, I keep asking myself the same thing!
Folks are very p*ssed at management and the financing certainly could have been on much more preferrable terms (before the share price was destroyed) but I think the dramatic market-cap reduction more than offsets the financial damage inflicted ... we now have funding so we are past this phase (to my understanding).
At this point, the science seems to be the most important factor as even a crappy management would not botch the clinical trials as the protocols are set/negotatiated with the FDA and we have funding to see things through.
Some concerns, however, about the science:
1. Could the trial results have been corrupted? I don't have much experience, but I've never heard about clinincal-trial fraud so I don't put much weight but perhaps it's something we need to consider, especially given the market skepticism.
2. Are the results not as strong as we are lead to believe? The trial does not have a random control group so perhaps there is some 'bias'. As an example off my head, perhaps in India the general population (and thus the patients) are generally much younger which is driving the survial rate higher (a 30 year old with cancer might have double the chance of survival than a 70 year old). Without a random control group such unforeseen factors are always possible. Furthermore, the result did not have ANY impact on median survival so the majority of patients were not impacted ... even by a small amount. If the treatment does indeed work to boost immune response, it could be the 'experts' were anticipating a more broad-based impact.
I've laid out what in my mind are the positive and negative fundamentals ... (which I wish was more common on these boards). Any further thoughts are certainly appreciated as I'm not an expert. I'm long but could be swayed otherwise.
Thanks for the information about the insider purchases .. that is certainly another positive!
It's part of the NTEK conspiracy to make Eric and Fred think there is still a partnership...
MCZ ... what the heck, I bought back in ... should have investigated more but I usually do better when I make these rash decisions!
I got out a while ago but have been following. What the CEO said about the gaming cycle makes pretty good sense ... I would think only more serious gamers would spend on these peripherals and these seem games are the ones soon to be upgrading to the new consoles.
I've not followed too closely, but it might be a good time to purchase some shares as Q4 could be strong with Christmas and then new gaming cycle.
Are you saying the main benefits of a partnership with NTEK are in doubt (VODWIZ) becasue VODWIZ was not mentioned explicity in a PR about Nuvola tradeshow?
So, this must be roughly what transpired?
NTEK: "We are no longer going to support the expansion plans for VODWIZ."
HHSE: "We are very unhappy with you so, in retaliation, please feel free to use one of our most aclaimed titles at your tradeshow."
Volume was MUCH greater on Monday ... perhaps the impact of the news occured then based on trading of insiders who might have had a preview of the results.